ORIC Pharmaceuticals, Inc. (ORIC) Tops Q4 EPS by 7c

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) reported Q4 EPS of ($0.30), $0.07 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on ORIC Pharmaceuticals, Inc. (ORIC) click here.

You May Also Be Interested In

• Chevron signed an agreement with Iraq's Basra Oil Company to advance commercial negotiations for West Qurna 2
• Surya Oil & Gas faces lawsuit over alleged oral agreement
• Trump: I asked Darline Graham to run for U.S. senate in special Republican primary on Tuesday, August 11